The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria
<p>A highly effective vaccine against malaria is urgently needed, with leading vaccination strategies involving the induction of protective antigen-specific CD8<sup>+</sup> T-cells via heterologous prime-boost viral vector immunization, targeting primarily the pre- erythrocytic liv...
Main Author: | |
---|---|
Other Authors: | |
Format: | Thesis |
Language: | English |
Published: |
2018
|
Subjects: |
_version_ | 1817933056344850432 |
---|---|
author | Gola, A |
author2 | Spencer, A |
author_facet | Spencer, A Gola, A |
author_sort | Gola, A |
collection | OXFORD |
description | <p>A highly effective vaccine against malaria is urgently needed, with leading vaccination strategies involving the induction of protective antigen-specific CD8<sup>+</sup> T-cells via heterologous prime-boost viral vector immunization, targeting primarily the pre- erythrocytic liver stages of the Plasmodium falciparum lifecycle. To date, the greatest immunogenicity has been obtained through a heterologous prime boost regimen, where vaccination with an Adenoviral vector is followed 8 weeks later by a Modified Vaccinia Ankara virus (MVA) boost. Experimental work directed at providing a greater understanding of CD8<sup>+</sup> T-cell memory responses induced by Ad-MVA vaccinations lead to the development of a novel vaccine strategy aimed at priming CD8<sup>+</sup> T-cells in the periphery and subsequently targeting them to hepatic tissue with protein loaded poly(lactic- co-glycolic acid) nanoparticles or recombinant viral vectors. Durable Ag-specific CD8+ T- cells exhibiting a phenotype of tissue-resident memory T-cells were generated in the liver, with a ten-fold increase over the conventional heterologous vector regimen. Importantly, in P. berghei sporozoite challenge models of liver-stage malaria, this strategy was found to result in unprecedented levels of sterile protection across multiple clinically relevant antigens and mouse strains. This prime and target immunization strategy for liver-stage malaria may provide a novel general approach for prevention or immunotherapy against other hepato-trophic pathogens.</p> |
first_indexed | 2024-03-06T21:50:34Z |
format | Thesis |
id | oxford-uuid:4b1ce436-316f-43da-bacf-3b1e178f2f40 |
institution | University of Oxford |
language | English |
last_indexed | 2024-12-09T03:47:44Z |
publishDate | 2018 |
record_format | dspace |
spelling | oxford-uuid:4b1ce436-316f-43da-bacf-3b1e178f2f402024-12-08T10:30:09ZThe role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malariaThesishttp://purl.org/coar/resource_type/c_db06uuid:4b1ce436-316f-43da-bacf-3b1e178f2f40VaccinologyImmunologyLiver-Stage MalariaEnglishORA Deposit2018Gola, ASpencer, AHill, AGermain, R<p>A highly effective vaccine against malaria is urgently needed, with leading vaccination strategies involving the induction of protective antigen-specific CD8<sup>+</sup> T-cells via heterologous prime-boost viral vector immunization, targeting primarily the pre- erythrocytic liver stages of the Plasmodium falciparum lifecycle. To date, the greatest immunogenicity has been obtained through a heterologous prime boost regimen, where vaccination with an Adenoviral vector is followed 8 weeks later by a Modified Vaccinia Ankara virus (MVA) boost. Experimental work directed at providing a greater understanding of CD8<sup>+</sup> T-cell memory responses induced by Ad-MVA vaccinations lead to the development of a novel vaccine strategy aimed at priming CD8<sup>+</sup> T-cells in the periphery and subsequently targeting them to hepatic tissue with protein loaded poly(lactic- co-glycolic acid) nanoparticles or recombinant viral vectors. Durable Ag-specific CD8+ T- cells exhibiting a phenotype of tissue-resident memory T-cells were generated in the liver, with a ten-fold increase over the conventional heterologous vector regimen. Importantly, in P. berghei sporozoite challenge models of liver-stage malaria, this strategy was found to result in unprecedented levels of sterile protection across multiple clinically relevant antigens and mouse strains. This prime and target immunization strategy for liver-stage malaria may provide a novel general approach for prevention or immunotherapy against other hepato-trophic pathogens.</p> |
spellingShingle | Vaccinology Immunology Liver-Stage Malaria Gola, A The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria |
title | The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria |
title_full | The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria |
title_fullStr | The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria |
title_full_unstemmed | The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria |
title_short | The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria |
title_sort | role of antigen in the maintenance and localisation of cd8 t cells in the context of liver stage malaria |
topic | Vaccinology Immunology Liver-Stage Malaria |
work_keys_str_mv | AT golaa theroleofantigeninthemaintenanceandlocalisationofcd8tcellsinthecontextofliverstagemalaria AT golaa roleofantigeninthemaintenanceandlocalisationofcd8tcellsinthecontextofliverstagemalaria |